Etanercept-induced SLE Antivalle M, Carrabba M, Bianchi-Porro G. Infliximab-induced lupus in Crohn’s disease: a case report. Dig Liver Dis 2003; 35: 814-7. 22. Ali Y, Shah S. Infliximab-induced systemic lupus erythematosus. Ann Intern Med 2002; 137: 625-6. 23. Garcia-Planella E, Domenech E, Esteve-Comas M, Bernal I, Cabre E, Boix J, Gassull MA. Development of antinuclear antibodies and its clinical impact in patients with Crohn’s disease treated with chimeric monoclonal anti-TNF antibodies (infliximab). Eur J Gastroenterol Hepatol 2003; 15: 351-4. 24. Vermeire S, Noman M, Van Assche G, Baert F, Van Steen K, Esters N, Joossens S, Bossuyt X, Rutgeerts P. Autoimmunity associated with 949 anti-tumor necrosis factor alpha treatment in Crohn’s disease: a pro- spective cohort study. Gastroenterology 2003; 125: 32-9. 25. Ledingham J, Deighton C, British Society for Rheumatology Stan- dards, Guidelines and Audit Working Group (SGAWG). Update on the British Society for Rheumatology guidelines for prescribing TNF- blockers in adults with rheumatoid arthritis (update of previous guide- lines of April 2001). Rheumatology 2005; 44: 157-63. 26. Hart SP, Dougherty GJ, Haslett C, Dransfield I. CD44 regulates pha- gocytosis of apoptotic neutrophil granulocytes, but not apoptotic lym- phocytes, by human macrophages. J Immunol 1997; 159: 919-25.